Droplet Digital PCR or Real-Time PCR as a Method for Quantifying SARS-CoV-2 RNA in Plasma-Is There a Difference?

Publication date: May 28, 2025

The aim of this study is to ascertain whether qRT-PCR (reverse transcriptase real-time PCR) or RT-ddPCR (reverse transcriptase digital droplet PCR) is more effective for detecting SARS-CoV-2 RNA (severe acute respiratory syndrome coronavirus 2 RNA) in blood plasma from COVID-19 (coronavirus infectious disease-19) patients. The E-gene of SARS-CoV-2 RNA was quantified using both methods in 128 plasma samples from 70 hospitalized patients, followed by a statistical analysis to compare the sensitivity and concordance between the methods. Out of the 128 samples, 89 yielded consistent results irrespective of the method used, whereas 39 samples showed discrepancies between the two different methods. RT-ddPCR frequently registered higher viral quantities compared to qRT-PCR; however, the results did not demonstrate a clear superiority in sensitivity for RT-ddPCR. Although RT-ddPCR registered higher viral quantities, this study concludes that both methods provide comparable results for detecting SARS-CoV-2 E-gene RNA in plasma.

Open Access PDF

Concepts Keywords
Blood Aged
Pcr COVID-19
Plasma COVID-19
Superiority E-gene
Viral Female
Humans
Male
plasma
qRT-PCR
RNA, Viral
RNA, Viral
RNAemia
RT-ddPCR
SARS-CoV-2
SARS-CoV-2
Sensitivity and Specificity
Viral Load

Semantics

Type Source Name
disease MESH COVID-19
disease MESH infectious disease
pathway REACTOME Infectious disease
drug DRUGBANK Serine
disease MESH infection
pathway KEGG Viral replication
disease IDO infectivity
disease IDO blood
disease MESH morbidity
disease MESH syndrome
disease MESH long COVID
disease IDO assay
drug DRUGBANK Edetic Acid
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH death
disease IDO nucleic acid
disease IDO pathogen
disease IDO cell
drug DRUGBANK Fluorescein
drug DRUGBANK Water
drug DRUGBANK Aspartame
disease MESH ramp
drug DRUGBANK Ademetionine
drug DRUGBANK Sodium lauryl sulfate
disease IDO process
disease IDO reagent
drug DRUGBANK Coenzyme M
drug DRUGBANK Etoperidone
disease IDO host
disease IDO protein
disease MESH Critically Ill
disease MESH Viral Load
disease MESH Fatal Outcomes
disease MESH Viremia
pathway REACTOME Immune System
disease MESH inflammation
disease IDO replication
disease MESH Complications
disease IDO immunodeficiency
drug DRUGBANK (S)-Des-Me-Ampa
drug DRUGBANK Guanosine
drug DRUGBANK Carboxyamidotriazole
drug DRUGBANK Dimercaprol
drug DRUGBANK Troleandomycin

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *